Zinc

Category
mineral
Routes
Oral (PO)
Half-Life (t½)
PO: 6h
Daily Value (RDI)
11 mg (UL: 40 mg)
Formula
Zn
Molecular Weight
65.38 g/mol
PubChem CID
23994
Aliases
Zn²⁺, Zinc picolinate, Zinc bisglycinate, Zinc monomethionine

Pharmacological Mechanism

Structural component of zinc-finger transcription factors (including AR, VDR, p53) and catalytic cofactor for carbonic anhydrase, alkaline phosphatase, DNA/RNA polymerases, and CuZn-SOD. Required for 5α-reductase and testicular testosterone synthesis. Intestinal uptake via ZIP4; efflux to portal blood via ZnT1. Competes with copper for DMT1 at high doses.

Dietary Reference Intake

FDA Daily Value 11 mg (21 CFR 101.9). NIH ODS UL 40 mg/d (copper antagonism above).

Half-Life & Elimination Curve (PO: 6h)

100%50%25%12.5%0%0h0×t½6h1×t½12h2×t½18h3×t½24h4×t½30h5×t½0×t½ (0h): 100% remaining (~0.314 mg/L)1×t½ (6h): 50% remaining (~0.157 mg/L)2×t½ (12h): 25% remaining (~78.5 µg/L)3×t½ (18h): 12.5% remaining (~39.2 µg/L)4×t½ (24h): 6.3% remaining (~19.6 µg/L)5×t½ (30h): 3.1% remaining (~9.81 µg/L)
Plasma (PO)t½ Decay (6h)
  • 0×t½0h100% (0.314 mg/L)
  • 1×t½6h50% (0.157 mg/L)
  • 2×t½12h25% (78.5 µg/L)
  • 3×t½18h12.5% (39.2 µg/L)
  • 4×t½24h6.3% (19.6 µg/L)
  • 5×t½30h3.1% (9.81 µg/L)
Elimination t½6h (PO)
Rate Constant (ke)0.116 h⁻¹
Time to Peak (Tmax)2.44h
Est. Peak (Cmax)0.314 mg/L
Clearance (CL)1.62 L/h
97% Washout (5×t½)30h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References